In the scores of intensities, the TRIM37 high-expression group, with a score ≥ 2 for tumor cells showing immunopositivity, showed significantly poorer overall survival (P = 0.0057, log-rank test) and relapse-free survival (P = 0.0288, log-rank test) compared with the low-expression group (Figure 1D and 1E). Here, TRIM37 is linked to neoplasm.